Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11654193 Cancer treatment combinations
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
May 8, 2020
0
Date of Patent
May 23, 2023
0
Patent Application Number
16870803
0
Patent Citations
US Patent 8992910 IL3Rα antibody conjugates and uses thereof
0
US Patent 9228023 Anti-ROR1 antibodies and methods of use for treatment of cancer
0
US Patent 9228208 Methods and compositions for the targeted modification of a genome
0
US Patent 9260512 Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
0
US Patent 9758591 Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
0
US Patent 10344096 Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
0
US Patent 10688181 Cancer treatment combinations
0
US Patent 7138501 Antibodies that immunospecifically bind BLyS
0
US Patent 7193069 Full-length cDNA
0
US Patent 7223393 Amphiregulin antibodies and their use to treat cancer and psoriasis
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11654193
0
Patent Primary Examiner
Karen A. Canella
0
CPC Code
A61K 2039/505
0
A61K 2300/00
0
A61K 45/06
0
Find more entities like US Patent 11654193 Cancer treatment combinations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE